BioCentury
ARTICLE | Distillery Therapeutics

Neurology

January 25, 2017 5:37 PM UTC

Cell culture and mouse studies suggest a modified ADCYAP1-derived peptide could help treat spinal and bulbar muscular atrophy (SBMA). In a mouse neuronal cell line expressing an SBMA-associated androg...